AEGiS-IRIN: SOUTH AFRICA: Global Fund withdraws support for loveLife UN Integrated Regional Information NetworkImportant note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Click here to return to UN Integrated Regional Information Network main menu
DonateNow




SOUTH AFRICA: Global Fund withdraws support for loveLife

Integrated Regional Information Networks - December 19, 2005


[This report does not necessarily reflect the views of the United Nations]

JOHANNESBURG, 19 December (PLUSNEWS) - The Global Fund to fight HIV/AIDS, Tuberculosis and Malaria has pulled the plug on financing loveLife, a controversial South African youth-targeted HIV/AIDS campaign.

In a statement the Global Fund board said it had found that loveLife "was deemed to not have sufficiently addressed weaknesses in its implementation".

Global Fund spokesman Jon Liden said it had become difficult to measure how the prevention campaign was contributing to the reduction of HIV/AIDS among young people.

Liden told PlusNews that the board had repeatedly requested loveLife to revise its proposals and address concerns regarding performance, financial and accounting procedures, and the need for an effective governance structure.

The campaign is aimed at 12 to 17 year-olds and is characterised by slick and stylish messaging, which many fret are not getting through to the majority of young South Africans.

In 2003, loveLife received about US $12 million from the Fund - a third of its operating budget.

Questions about the impact of the well-funded campaign have generated considerable debate, and more than two years after it began providing financial support, the Global Fund now wants some answers.

"This is a Fund with limited resources ... loveLife is extremely costly - there are programmes that have been very effective, which cost a fraction of what loveLife costs. It would be irresponsible of the Global Fund to spend almost $40 million without seeing results," Liden noted.

However, the programme's deputy CEO, Grace Matlhape, stressed that "loveLife is working".

She pointed to a 2004 study conducted by the University of Witwatersrand's Reproductive Health Research Unit - a loveLife partner - which revealed that of more than 11,000 young people aged between 15 and 24, those who had participated in a number of loveLife programmes were less likely to be HIV-positive, and were also more likely to report using condoms and be tested for HIV.

But the study did not clarify whether the project had caused these differences.

While admitting that the scale of the epidemic made it difficult to gauge the impact of the campaign, Matlhape called for greater investment in prevention efforts like LoveLife.

"This is a decision that affects all South Africans, and is probably more politically driven than anything else," she noted.

Liden countered, "instead of dismissing this as political, this is an opportunity for Lovelife to reflect on why one of the biggest AIDS funders in the world decided not to fund its activities".


051219
IR051246


Copyright © 2005 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980 – 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .